IR-Med Appoints New CEO, Dr. Yaron Paz
Ticker: IRME · Form: 8-K · Filed: Aug 28, 2024 · CIK: 1839133
| Field | Detail |
|---|---|
| Company | Ir-Med, Inc. (IRME) |
| Form Type | 8-K |
| Filed Date | Aug 28, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $4,000,000, $0.001, $0.58 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, executive-appointment, executive-resignation
TL;DR
IR-Med has a new CEO, Dr. Yaron Paz, effective Aug 21. Old CEO out, CFO Aviad Mizrahi in.
AI Summary
IR-Med, Inc. announced on August 28, 2024, that its Board of Directors appointed Dr. Yaron Paz as Chief Executive Officer, effective August 21, 2024. Dr. Paz, who has been a director since 2023, will also continue his role as Chief Medical Officer. The company also announced the resignation of its previous CEO, Mr. Shimon Mizrahi, and the appointment of Mr. Aviad Mizrahi as Chief Financial Officer.
Why It Matters
The appointment of a new CEO and CFO signifies a potential shift in leadership and strategic direction for IR-Med, Inc., which could impact its future operations and market performance.
Risk Assessment
Risk Level: medium — Changes in key executive positions like CEO and CFO can introduce uncertainty and potential execution risks for a company.
Key Players & Entities
- IR-Med, Inc. (company) — The company filing the report.
- Dr. Yaron Paz (person) — Appointed Chief Executive Officer and continues as Chief Medical Officer.
- August 21, 2024 (date) — Effective date of Dr. Yaron Paz's appointment as CEO.
- August 28, 2024 (date) — Date of the report.
- Mr. Shimon Mizrahi (person) — Resigned Chief Executive Officer.
- Mr. Aviad Mizrahi (person) — Appointed Chief Financial Officer.
FAQ
Who has been appointed as the new CEO of IR-Med, Inc.?
Dr. Yaron Paz has been appointed as the new Chief Executive Officer of IR-Med, Inc.
When was Dr. Yaron Paz's appointment as CEO effective?
Dr. Yaron Paz's appointment as CEO was effective August 21, 2024.
What other role does Dr. Yaron Paz hold at IR-Med, Inc.?
Dr. Yaron Paz will continue in his role as Chief Medical Officer.
Who has been appointed as the new CFO of IR-Med, Inc.?
Mr. Aviad Mizrahi has been appointed as the new Chief Financial Officer.
Who resigned as CEO of IR-Med, Inc.?
Mr. Shimon Mizrahi resigned as Chief Executive Officer.
Filing Stats: 938 words · 4 min read · ~3 pages · Grade level 10.4 · Accepted 2024-08-28 16:05:24
Key Financial Figures
- $4,000,000 — 6,000 until the Company raises at least $4,000,000 in funding, and following such potentia
- $0.001 — d shares of the Company's common stock, $0.001 par value per share (the "Common Stock"
- $0.58 — Common Stock"), at an exercise price of $0.58 per share (the "Shares"). The Shares wi
Filing Documents
- form8-k.htm (8-K) — 43KB
- ex10-1.htm (EX-10.1) — 155KB
- ex99-1.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 32KB
- 0001493152-24-034186.txt ( ) — 455KB
- irme-20240828.xsd (EX-101.SCH) — 3KB
- irme-20240828_lab.xml (EX-101.LAB) — 33KB
- irme-20240828_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IR-Med, Inc. By: /s/ Sharon Lefkoviz Name: Sharon Lefkoviz Title: Chief Financial Officer Date: August 28, 2024